IOSP
IOSP
NASDAQ · Chemicals

Innospec Inc

$78.82
-1.83 (-2.27%)
As of Nov 5, 8:55 PM ET ·
Financial Highlights (FY 2026)
Revenue
1.76B
Net Income
115.16M
Gross Margin
27.7%
Profit Margin
6.6%
Rev Growth
-3.3%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 27.7% 27.7% 47.6% 47.6%
Operating Margin 7.3% 6.6% 11.9% 13.3%
Profit Margin 6.6% 6.2% 10.5% 9.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.76B 1.82B 1.16B 1.31B
Gross Profit 486.25M 502.64M 550.75M 621.95M
Operating Income 127.84M 118.93M 137.91M 173.27M
Net Income 115.16M 107.14M 121.69M 129.51M
Gross Margin 27.7% 27.7% 47.6% 47.6%
Operating Margin 7.3% 6.6% 11.9% 13.3%
Profit Margin 6.6% 6.2% 10.5% 9.9%
Rev Growth -3.3% -3.3% +1.1% -8.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 175.29M 181.16M
Total Equity — — 1.11B 1.03B
D/E Ratio — — 0.16 0.18
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 137.68M 135.20M 208.77M 249.95M
Free Cash Flow — — 164.95M 158.97M